The AstraZeneca vaccine, from tomorrow in Italy “can also be administered in the range from 60 to 79 years”. The emergency commissioner said so Francesco Paolo Figliuolo during the meeting between the Government and the Regions following the new assessments of the EMA which recognized possible rare links with cases of thrombosis.

On the same line the coordinator of the Cts Franco Locatelli which would have recommended privileging the over 60 age group for the Anglo-Swedish vaccine.

“Ema and Aifa have evaluated new data on the development of thrombotic phenomena – he explained – the evaluation made by the Ema committee is that the causal link has been declared as plausible and the mechanism underlying these complications is not clarified but hypotheses suggest the ‘activation of autoimmunity ”.

Thrombotic events were higher than expected under the age of 60 and most occurred in women under the age of 60 but the EMA said there are no identified risk factors, and most within 14 days of vaccine and only after the first administration “.

AstraZeneca, Hope: “A short document with clear indications”

For the change of address on AstraZeneca there will be “a provision, with all the indications”, said the Minister of Health Roberto Speranza speaking at the meeting of the Government with Regions, Provinces and Municipalities on the AstraZeneca case.

“We immediately start writing the circular. We need to be clear and clear ”, said the minister. The provision “will contain a recommendation to administer AstraZeneca over the age of 60, in line with what has been decided by other EU countries,” he added.

AstraZeneca, does not compromise the goal of 500 thousand vaccines a day

The possibility of allocating the doses of the AstraZeneca vaccine to the over 60s, shielding the youngest with Pfizer, Moderna and J&J, “would not compromise the goal that Prime Minister Mario Draghi has indicated, namely to reach 500 thousand vaccinations per day at the end of the month.

The possible remodeling of the administration of the Anglo-Swedish vaccine “in theory should not affect that much – say the same sources – in fact it is an incentive to vaccinate the over-60s more”.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.